What a 510(k) clearance actually says

Cleared is not approved

Most energy-based aesthetic devices reach the United States market through a 510(k) premarket notification, named for the section of the Federal Food, Drug, and Cosmetic Act that creates it. The FDA clears a 510(k). It approves a premarket approval application, which is a different and much heavier pathway used mainly for Class III devices.

So “FDA approved” is usually the wrong phrase for a device in this category, and using it is one of the faster ways for a company to attract a warning letter.

What a 510(k) actually demonstrates

A 510(k) demonstrates that the device is substantially equivalent to a legally marketed predicate device: same intended use, and either the same technological characteristics or different ones that raise no new questions of safety and effectiveness. It is a comparison to something already on the market. It is generally not a fresh demonstration that the device produces a particular clinical result.

The Indications for Use statement

Every clearance carries an Indications for Use statement, and that sentence is the legal boundary of what the manufacturer may claim. It is frequently written in mechanistic language, for example hemostasis and electrocoagulation, which describes what the energy does to tissue rather than what a provider is treating in the room.

That gap is not a loophole and it is not anyone behaving badly. It is the predictable result of a pathway built around equivalence to a predicate rather than around the outcome a patient came in for.

Why this matters commercially

A provider wants to know whether the device helps with acne scarring, what settings to run on a darker skin type, and how many sessions to plan. A manufacturer is bounded by its cleared indication. Nobody in that conversation is being evasive; the sentence they are allowed to say simply does not answer the question being asked.